Crossref
Could a popular antiviral supercharge the pandemic?
Science · 2023
DOI: 10.1126/science.adh0582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2023. Verfasst von Robert F Service. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19, Pandemics, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Molnupiravir appears to be speeding SARS-CoV-2 evolution
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Antiviral AgentsCOVID-19PandemicsSARS-CoV-2HydroxylaminesGenome, ViralHumansMutationRisk AssessmentCytidine
Substanzen
Antiviral AgentsHydroxylaminesmolnupiravirCytidine
Zitieren
APA
Service, R. F. (2023). Could a popular antiviral supercharge the pandemic?. Science. https://doi.org/10.1126/science.adh0582
Vancouver
Service RF. Could a popular antiviral supercharge the pandemic?. Science. 2023. doi:10.1126/science.adh0582
BibTeX
@article{Service2023,
author = {Service, Robert F},
title = {Could a popular antiviral supercharge the pandemic?},
journal = {Science},
year = {2023},
doi = {10.1126/science.adh0582}
}
EUVIMED